Buraggi GL - Search Results

1

Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody.

Crippa F, Buraggi GL, Di Re E, Gasparini M, Seregni E, Canevari S, Gadina M, Presti M, Marini A, Seccamani E. Crippa F, et al. Among authors: buraggi gl. Eur J Cancer. 1991;27(6):724-9. doi: 10.1016/0277-5379(91)90174-c. Eur J Cancer. 1991. PMID: 1829912

2

Monoclonal anti-CEA antibody: factors affecting localization in a preclinical study.

Ripamonti M, Canevari S, Buraggi G, Gadina M, Turrin A, Gasparini M, Scassellati G, Colnaghi MI. Ripamonti M, et al. Int J Biol Markers. 1988 Oct-Dec;3(4):249-58. doi: 10.1177/172460088800300406. Int J Biol Markers. 1988. PMID: 3235853

3

Immunoscintigraphy of colorectal carcinoma with an anti-CEA monoclonal antibody: a critical review.

Buraggi GL, Gasparini M, Seregni E. Buraggi GL, et al. Int J Rad Appl Instrum B. 1991;18(1):45-50. doi: 10.1016/0883-2897(91)90045-m. Int J Rad Appl Instrum B. 1991. PMID: 2010305 Review.

4

Clinical value of radioimmunoscintigraphy in the follow-up of ovarian carcinoma: a prospective study.

Crippa F, Presti M, Marini A, D'Onofrio B, Bolis G, Buraggi GL. Crippa F, et al. Among authors: buraggi gl. Int J Biol Markers. 1990 Jul-Sep;5(3):103-8. Int J Biol Markers. 1990. PMID: 2286774

5

Tumor imaging of colo-rectal carcinoma with an anti-CEA monoclonal antibody.

Gasparini M, Ripamonti M, Seregni E, Regalia E, Buraggi GL. Gasparini M, et al. Among authors: buraggi gl. Int J Cancer Suppl. 1988;2:81-4. doi: 10.1002/ijc.2910410719. Int J Cancer Suppl. 1988. PMID: 3162449

6

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer.

Crippa F, Bolis G, Seregni E, Gavoni N, Scarfone G, Ferraris C, Buraggi GL, Bombardieri E. Crippa F, et al. Among authors: buraggi gl. Eur J Cancer. 1995;31A(5):686-90. doi: 10.1016/0959-8049(94)00454-d. Eur J Cancer. 1995. PMID: 7640039

7

Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.

Bombardieri E, Crippa F, Cataldo I, Chiti A, Seregni E, Soresi E, Boffi R, Invernizzi G, Buraggi GL. Bombardieri E, et al. Among authors: buraggi gl. Eur J Cancer. 1995;31A(2):184-8. doi: 10.1016/0959-8049(94)00467-j. Eur J Cancer. 1995. PMID: 7718323

8

Radioimmunodetection of melanoma: preliminary results of a prospective study.

Buraggi G, Turrin A, Cascinelli N, Attili A, Gasparini M, Callegaro L, Ferrone S, Seregni E, Bombardieri E, Belli F. Buraggi G, et al. Int J Biol Markers. 1986 Jan-Apr;1(1):47-54. doi: 10.1177/172460088600100108. Int J Biol Markers. 1986. PMID: 2826619

9

Anti-melanoma monoclonal antibody 225-28S: evaluation of toxicity in man.

Cascinelli N, Attili A, Belli F, Buraggi G, Turrin A, Gasparini M, Terno G, Vaglini M. Cascinelli N, et al. Tumori. 1988 Feb 29;74(1):35-40. doi: 10.1177/030089168807400106. Tumori. 1988. PMID: 3354062

10

Radioimmunotherapy of ovarian cancer with radiolabelled monoclonal antibodies: biological basis, present status and future perspectives.

Bombardieri E, Ferrari L, Spinelli A, Maffioli L, Seregni E, Buraggi G. Bombardieri E, et al. Anticancer Res. 1997 May-Jun;17(3B):1719-29. Anticancer Res. 1997. PMID: 9179225 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters